SCCM Neuroscience Section/X
Nov 6, 2025, 07:08
Study Finds NOACs as Safe and Effective as Warfarin in CVST
SCCM Neuroscience Section posted on X:
”Use of new oral anticoagulants (NOACs) in cerebral venous sinus thrombosis (CVST) has similar efficacy and safety compared to warfarin treatment.
NOACs treatment may improve clinical prognosis in pts with CVST.”
Read the study here.
Title: Anticoagulant Therapy for Cerebral Venous Sinus Thrombosis: A Propensity Score Matching Study and Inverse Probability Weighting
Authors: Kai Liu, Mengmeng Zhang, Jiawei Zhao, Qinqin Dai, Yuan Gao, Shen Li, Lu Zhao, Yuming Xu, Bo Song

Stay informed with Hemostasis Today.
Anticoagulation
Bo Song
cerebral venous sinus thrombosis
CVST
Direct Oral Anticoagulants
DOACs
Health
Hematology
Hemostasis
Hemostasis Today
Jiawei Zhao
Kai Liu
Lu Zhao
Medicine
Mengmeng Zhang
New OralAnticoagulants
NOACs
Qinqin Dai
SCCM Neuroscience Section
Shen Li
thrombosis
Venous Thrombosis
Warfarin
Yuan Gao
Yuming Xu
-
Jul 3, 2026, 23:08For Jatinder Minhas, The Strength of Simulation Training Is Learning Together Across Disciplines – ESO
-
Jul 3, 2026, 22:47Khaled Musallam: Caring for Women with Thalassemia From Puberty to Pregnancy and Beyond
-
Jul 3, 2026, 21:25Matteo Foschi: Happy to Join the Italian Stroke Association Summer School
-
Jul 3, 2026, 20:39Maha Othman: Excited to Present on PPH for The Lancet Haematology Commission on Global Female Health
-
Jul 3, 2026, 19:15Edward Lee Carter: Anticoagulation Drift – The Patient Changes, the Plan Should Too
-
Jul 3, 2026, 19:15Marcelo Soares: Cytokine and Lymphocyte Profiles of Cancer Patients With COVID-19
-
Jul 3, 2026, 19:13Anwar Elshikh: Calciphylaxis and Skin Issues in Renal Failure Patients
-
Jul 3, 2026, 19:11Amr M. Fahmi: Genotype-Guided Warfarin Dosing in the Arab Population
-
Jul 3, 2026, 19:10Isabella Presch: A Step Toward Greater Regulatory Clarity in Genome-Editing Therapeutics